Protara Therapeutics, Inc. (TARA)
USD 5.16
(-8.19%)
USD 5.16
(-8.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 341 Thousand | 247 Thousand | 1.16 Million | 196 Thousand | 16 Thousand | 115 Thousand |
| Gross Profit | -341 Thousand | -247 Thousand | -1.16 Million | -196 Thousand | -16 Thousand | -115 Thousand |
| Operating Expenses | 43.61 Million | 37.54 Million | 47.48 Million | 34.44 Million | 15.25 Million | 26.08 Million |
| Selling, General and Administrative Expenses | 18.62 Million | 20.73 Million | 26.4 Million | 22.46 Million | 8.81 Million | 10.57 Million |
| Research and Development Expenses | 24.98 Million | 16.8 Million | 21.08 Million | 11.98 Million | 6.43 Million | 15.5 Million |
| Other Expenses | - | 29.51 Million | - | - | - | 207 Thousand |
| Cost and Expenses | 43.61 Million | 37.54 Million | 47.48 Million | 34.44 Million | 15.25 Million | 26.08 Million |
| Operating Income | -43.61 Million | -67.06 Million | -47.48 Million | -34.44 Million | -15.25 Million | -26.08 Million |
| Interest Expense | - | 1.13 Million | 1.73 Million | 34 Thousand | - | - |
| Income Tax Expense | - | -1.13 Million | -117 Thousand | -466 Thousand | -262 Thousand | 5.35 Million |
| Earnings before Tax | -40.42 Million | -65.95 Million | -47.25 Million | -33.97 Million | -14.99 Million | -25.43 Million |
| Net Income | -40.42 Million | -64.81 Million | -47.13 Million | -33.51 Million | -14.73 Million | -25.43 Million |
| Earnings Per Share Basic | -3.57 | -5.76 | -4.20 | -4.63 | -228.60 | -9.93 |
| Earnings Per Share Diluted | -3.57 | -5.76 | -4.20 | -4.63 | -228.60 | -9.93 |
| Weighted Average Shares Outstanding | 11.33 Million | 11.25 Million | 11.23 Million | 7.23 Million | 64.43 Thousand | 2.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.33 Million | 11.25 Million | 11.23 Million | 7.23 Million | 64.43 Thousand | 2.56 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -43.27 Million | -64.56 Million | -46.08 Million | -33.78 Million | -7.81 Million | -20.61 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.2 Million | - | - | - |
| Cost of Revenue | 83 Thousand | 83 Thousand | 107 Thousand | 341 Thousand | 107 Thousand | 420 Thousand |
| Gross Profit | -83 Thousand | -83 Thousand | 1.1 Million | -341 Thousand | -107 Thousand | -420 Thousand |
| Operating Expenses | 10.57 Million | 11.76 Million | 10.93 Million | 43.27 Million | 10.7 Million | 12.14 Million |
| Selling, General and Administrative Expenses | 4.27 Million | 4.1 Million | 4.55 Million | - | 4.48 Million | 4.89 Million |
| Research and Development Expenses | 6.3 Million | 7.66 Million | 6.38 Million | - | 6.21 Million | 7.24 Million |
| Other Expenses | - | - | - | -204 Thousand | - | - |
| Cost and Expenses | 10.66 Million | 11.85 Million | 11.04 Million | 43.61 Million | 10.7 Million | 12.14 Million |
| Operating Income | -10.66 Million | -11.85 Million | -11.04 Million | -43.61 Million | -10.7 Million | -12.14 Million |
| Interest Expense | - | - | 687 Thousand | - | - | - |
| Income Tax Expense | - | 39.72 Thousand | 1.64 Million | -341 Thousand | -107 Thousand | -846 Thousand |
| Earnings before Tax | -9.51 Million | -11.09 Million | -10.22 Million | -40.42 Million | -9.86 Million | -11.29 Million |
| Net Income | -9.51 Million | -11.09 Million | -10.22 Million | -40.42 Million | -9.86 Million | -11.29 Million |
| Earnings Per Share Basic | -0.45 | -0.97 | -0.90 | - | -0.87 | -1.00 |
| Earnings Per Share Diluted | -0.45 | -0.97 | -0.90 | - | -0.87 | -1.00 |
| Weighted Average Shares Outstanding | 21.23 Million | 11.42 Million | 11.36 Million | 11.33 Million | 11.34 Million | 11.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.23 Million | 11.42 Million | 11.36 Million | 11.33 Million | 11.34 Million | 11.3 Million |
| Gross Margin | - | - | 0.91 | - | - | - |
| EBIT Margin | - | - | -9.05 | - | - | - |
| Profit Margin | - | - | -8.46 | - | - | - |
| EBITDA | -10.57 Million | -11.76 Million | -10.93 Million | - | -10.7 Million | -12.06 Million |
| Earnings Before Tax Margin | - | - | -9.14 | - | - | - |
SPDV
688255
SNANF
GCI
002132
600606